| Citation: |
ZHU Xiangyu, SHI Yan, FU Jing. Impact of timing of continuous renal replacement therapy on the efficacy and prognosis of patients with septic shock undergoing bundle therapy[J]. Journal of Clinical Medicine in Practice, 2024, 28(21): 66-69, 76. DOI: 10.7619/jcmp.20241850
|
To investigate the impact of the timing of continuous renal replacement therapy (CRRT) on the efficacy and prognosis of patients with septic shock undergoing bundle therapy.
A total of 84 patients with septic shock who underwent bundle therapy were enrolled, receiving bundle therapy. Based on the timing of CRRT, the patients were divided into early CRRT group and late CRRT group, with 42 patients in each group. Clinical data (heart rate, time to normalization of body temperature, ICU length of stay) and infection status[C-reactive protein (CRP), procalcitonin (PCT)]and immune function (CD4+, CD8+, CD14+), as well as the Acute Physiology and Chronic Health Evaluation Ⅱ (APACHE Ⅱ) scores before and after treatment were compared between the two groups. The 28-day survival of patients in both groups was also followed up.
The heart rate in the early CRRT group was lower than that in the late CRRT group, and the time to normalization of body temperature and ICU length of stay were shorter in the early CRRT group compared with the late CRRT group (P < 0.05). After treatment, the levels of CRP and PCT in both groups were lower than those before treatment, and their levels in the early CRRT group were lower than those in the late CRRT group (P < 0.05). After treatment, the levels of CD8+ in both groups were lower than those before treatment, and the early CRRT group had lower level than that in the late CRRT group (P < 0.05); after treatment, the levels of CD4+ and CD14+ in both groups were higher than those before treatment, and their levels in the early CRRT group were higher than those in the late CRRT group (P < 0.05). After treatment, the APACHE Ⅱ scores of both groups were lower than those before treatment, and the early CRRT group had lower APACHE Ⅱ score than that in the late CRRT group (P < 0.05). The follow-up results showed that the 28-day cumulative survival rate was 83.33%(35/42) in the early CRRT group, which was higher than 64.29%(27/42) in the late CRRT group (P < 0.05).
For patients with septic shock undergoing bundle therapy, early application of CRRT is superior to late application in clinical efficacy, and contributes to improving the prognosis of patients.
| [1] |
LIU D, HUANG S Y, SUN J H, et al. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options[J]. Mil Med Res, 2022, 9(1): 56.
|
| [2] |
DE BACKER D, RICOTTILLI F, OSPINA-TASCÓN G A. Septic shock: a microcirculation disease[J]. Curr Opin Anaesthesiol, 2021, 34(2): 85-91. doi: 10.1097/ACO.0000000000000957
|
| [3] |
LIU Y C, YAO Y, YU M M, et al. Frequency and mortality of sepsis and septic shock in China: a systematic review and meta-analysis[J]. BMC Infect Dis, 2022, 22(1): 564. doi: 10.1186/s12879-022-07543-8
|
| [4] |
GAVELLI F, CASTELLO L M, AVANZI G C. Management of sepsis and septic shock in the emergency department[J]. Intern Emerg Med, 2021, 16(6): 1649-1661. doi: 10.1007/s11739-021-02735-7
|
| [5] |
郭妍妍, 曹延会. 液体正平衡对严重脓毒症性急性肾损伤预后的影响[J]. 中华保健医学杂志, 2020, 22(1): 9-11.
|
| [6] |
NORSE A B, GUIRGIS F, BLACK L P, et al. Updates and controversies in the early management of sepsis and septic shock[J]. Emerg Med Pract, 2021, 23: 1-24.
|
| [7] |
HAKEMI M S, NASSIRI A A, NOBAKHT A, et al. Benefit of hemoadsorption therapy in patients suffering sepsis-associated acute kidney injury: a case series[J]. Blood Purif, 2022, 51(10): 823-830. doi: 10.1159/000521228
|
| [8] |
FENG J Q, ZHANG S Y, AI T Y, et al. Effect of CRRT with oXiris filter on hemodynamic instability in surgical septic shock with AKI: a pilot randomized controlled trial[J]. Int J Artif Organs, 2022, 45(10): 801-808. doi: 10.1177/03913988221107947
|
| [9] |
中华医学会重症医学分会. 中国严重脓毒症/脓毒性休克治疗指南(2014)[J]. 中华内科杂志, 2015, 54(6): 557-581.
|
| [10] |
范孟静, 段美丽, 林瑾, 等. 血清sTM、PCT、CRP/PAB比值与脓毒症患者APACHEⅡ评分、SOFA评分的相关性及其联合检测对预后的预测价值[J]. 现代生物医学进展, 2023, 23(4): 660-665.
|
| [11] |
JACOBI J. The pathophysiology of sepsis - 2021 update: part 2, organ dysfunction and assessment[J]. Am J Health Syst Pharm, 2022, 79(6): 424-436.
|
| [12] |
KARAMPELA I, FRAGKOU P C. Future perspectives in the diagnosis and treatment of sepsis and septic shock[J]. Medicina, 2022, 58(7): 844.
|
| [13] |
SHORR A F, ZILBERBERG M D. Sepsis and septic shock: evolving evidence, evolving paradigms[J]. Semin Respir Crit Care Med, 2022, 43(1): 39-45.
|
| [14] |
CHIU C, LEGRAND M. Epidemiology of sepsis and septic shock[J]. Curr Opin Anaesthesiol, 2021, 34(2): 71-76.
|
| [15] |
HELLMAN T, UUSALO P, JÄRVISALO M J. Renal replacement techniques in septic shock[J]. Int J Mol Sci, 2021, 22(19): 10238.
|
| [16] |
LIU S Q, CAO Q X, SUN R, et al. Application of different continuous renal replacement therapy hemofilter in patients with septic shock complicated with acute renal injury[J]. Iran J Public Health, 2022, 51(10): 2317-2324.
|
| [17] |
王馨怡. 成人体外循环心脏大血管术后急性肾损伤行连续性肾脏替代治疗的预后分析[D]. 遵义: 遵义医科大学, 2020.
|
| [18] |
高梅. 连续性肾脏替代治疗应用于体外膜肺氧合患者的临床疗效分析[D]. 郑州: 河南大学, 2022.
|
| [19] |
MARQUES A, TORRE C, PINTO R, et al. Treatment advances in sepsis and septic shock: modulating pro- and anti-inflammatory mechanisms[J]. J Clin Med, 2023, 12(8): 2892.
|
| [20] |
LI Q, YAN W W, LIU S, et al. Study on the correlation and clinical significance of T-lymphocyte Subsets, IL-6 and PCT in the severity of patients with sepsis[J]. Pak J Med Sci, 2023, 39(1): 227-231.
|
| [21] |
郝翠平, 胡庆河, 朱丽娜, 等. 血乳酸和降钙素原与病情严重程度评分对脓毒性休克患者短期预后的联合预测价值[J]. 中华危重病急救医学, 2021, 33(3): 281-285.
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: